• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and United States Glaucoma Pharmaceutical Market Insights, Forecast to 2026

report cover
  • 4 September 2020
  • Pharmaceuticals
  • 129 Pages
  • Report Code: 24LS-21562
  • Formate :   
Download FREE Report Sample Download PDF File

United States Glaucoma Pharmaceutical -MARKET ADVISORY SERVICES

Glaucoma Pharmaceutical market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Glaucoma Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Glaucoma Pharmaceutical market is segmented into
Miosis Drugs
Beta-blocker
Adrenergic Agonists
Carbonic Anhydrase Inhibitor
Prostaglandin Derivative Agent
Penetrates

Segment by Application, the Glaucoma Pharmaceutical market is segmented into
Hospital Pharmacy
Drugstore
Online Sales

Regional and Country-level Analysis
The Glaucoma Pharmaceutical market is analysed and market size information is provided by regions (countries).
The key regions covered in the Glaucoma Pharmaceutical market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Glaucoma Pharmaceutical Market Share Analysis
Glaucoma Pharmaceutical market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glaucoma Pharmaceutical business, the date to enter into the Glaucoma Pharmaceutical market, Glaucoma Pharmaceutical product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Merck
Allergan
Santen
Alcon
Teva Pharmaceuticals
Fera Pharmaceuticals
Bausch & Lomb, Inc.
Akorn, Inc.
1 Study Coverage
1.1 Glaucoma Pharmaceutical Product Introduction
1.2 Market Segments
1.3 Key Glaucoma Pharmaceutical Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Glaucoma Pharmaceutical Market Size Growth Rate by Type
1.4.2 Miosis Drugs
1.4.3 Beta-blocker
1.4.4 Adrenergic Agonists
1.4.5 Carbonic Anhydrase Inhibitor
1.4.6 Prostaglandin Derivative Agent
1.4.7 Penetrates
1.5 Market by Application
1.5.1 Global Glaucoma Pharmaceutical Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Drugstore
1.5.4 Online Sales
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Glaucoma Pharmaceutical Market Size, Estimates and Forecasts
2.1.1 Global Glaucoma Pharmaceutical Revenue 2015-2026
2.1.2 Global Glaucoma Pharmaceutical Sales 2015-2026
2.2 Global Glaucoma Pharmaceutical, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Glaucoma Pharmaceutical Historical Market Size by Region (2015-2020)
2.3.1 Global Glaucoma Pharmaceutical Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Glaucoma Pharmaceutical Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Glaucoma Pharmaceutical Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Glaucoma Pharmaceutical Sales Forecast by Region (2021-2026)
2.4.2 Global Glaucoma Pharmaceutical Revenue Forecast by Region (2021-2026)

3 Global Glaucoma Pharmaceutical Competitor Landscape by Players
3.1 Global Top Glaucoma Pharmaceutical Sales by Manufacturers
3.1.1 Global Glaucoma Pharmaceutical Sales by Manufacturers (2015-2020)
3.1.2 Global Glaucoma Pharmaceutical Sales Market Share by Manufacturers (2015-2020)
3.2 Global Glaucoma Pharmaceutical Manufacturers by Revenue
3.2.1 Global Glaucoma Pharmaceutical Revenue by Manufacturers (2015-2020)
3.2.2 Global Glaucoma Pharmaceutical Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Glaucoma Pharmaceutical Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Glaucoma Pharmaceutical Revenue in 2019
3.2.5 Global Glaucoma Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Glaucoma Pharmaceutical Price by Manufacturers
3.4 Global Glaucoma Pharmaceutical Manufacturing Base Distribution, Product Types
3.4.1 Glaucoma Pharmaceutical Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glaucoma Pharmaceutical Product Type
3.4.3 Date of International Manufacturers Enter into Glaucoma Pharmaceutical Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Glaucoma Pharmaceutical Market Size by Type (2015-2020)
4.1.1 Global Glaucoma Pharmaceutical Sales by Type (2015-2020)
4.1.2 Global Glaucoma Pharmaceutical Revenue by Type (2015-2020)
4.1.3 Glaucoma Pharmaceutical Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Glaucoma Pharmaceutical Market Size Forecast by Type (2021-2026)
4.2.1 Global Glaucoma Pharmaceutical Sales Forecast by Type (2021-2026)
4.2.2 Global Glaucoma Pharmaceutical Revenue Forecast by Type (2021-2026)
4.2.3 Glaucoma Pharmaceutical Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Glaucoma Pharmaceutical Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Glaucoma Pharmaceutical Market Size by Application (2015-2020)
5.1.1 Global Glaucoma Pharmaceutical Sales by Application (2015-2020)
5.1.2 Global Glaucoma Pharmaceutical Revenue by Application (2015-2020)
5.1.3 Glaucoma Pharmaceutical Price by Application (2015-2020)
5.2 Glaucoma Pharmaceutical Market Size Forecast by Application (2021-2026)
5.2.1 Global Glaucoma Pharmaceutical Sales Forecast by Application (2021-2026)
5.2.2 Global Glaucoma Pharmaceutical Revenue Forecast by Application (2021-2026)
5.2.3 Global Glaucoma Pharmaceutical Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Glaucoma Pharmaceutical Market Size YoY Growth 2015-2026
6.1.1 United States Glaucoma Pharmaceutical Sales YoY Growth 2015-2026
6.1.2 United States Glaucoma Pharmaceutical Revenue YoY Growth 2015-2026
6.1.3 United States Glaucoma Pharmaceutical Market Share in Global Market 2015-2026
6.2 United States Glaucoma Pharmaceutical Market Size by Players (International and Local Players)
6.2.1 United States Top Glaucoma Pharmaceutical Players by Sales (2015-2020)
6.2.2 United States Top Glaucoma Pharmaceutical Players by Revenue (2015-2020)
6.3 United States Glaucoma Pharmaceutical Historic Market Review by Type (2015-2020)
6.3.1 United States Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
6.3.2 United States Glaucoma Pharmaceutical Revenue Market Share by Type (2015-2020)
6.3.3 United States Glaucoma Pharmaceutical Price by Type (2015-2020)
6.4 United States Glaucoma Pharmaceutical Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Glaucoma Pharmaceutical Sales Forecast by Type (2021-2026)
6.4.2 United States Glaucoma Pharmaceutical Revenue Forecast by Type (2021-2026)
6.4.3 United States Glaucoma Pharmaceutical Price Forecast by Type (2021-2026)
6.5 United States Glaucoma Pharmaceutical Historic Market Review by Application (2015-2020)
6.5.1 United States Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)
6.5.2 United States Glaucoma Pharmaceutical Revenue Market Share by Application (2015-2020)
6.5.3 United States Glaucoma Pharmaceutical Price by Application (2015-2020)
6.6 United States Glaucoma Pharmaceutical Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Glaucoma Pharmaceutical Sales Forecast by Application (2021-2026)
6.6.2 United States Glaucoma Pharmaceutical Revenue Forecast by Application (2021-2026)
6.6.3 United States Glaucoma Pharmaceutical Price Forecast by Application (2021-2026)

7 North America
7.1 North America Glaucoma Pharmaceutical Market Size YoY Growth 2015-2026
7.2 North America Glaucoma Pharmaceutical Market Facts & Figures by Country
7.2.1 North America Glaucoma Pharmaceutical Sales by Country (2015-2020)
7.2.2 North America Glaucoma Pharmaceutical Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Glaucoma Pharmaceutical Market Size YoY Growth 2015-2026
8.2 Europe Glaucoma Pharmaceutical Market Facts & Figures by Country
8.2.1 Europe Glaucoma Pharmaceutical Sales by Country
8.2.2 Europe Glaucoma Pharmaceutical Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Glaucoma Pharmaceutical Market Size YoY Growth 2015-2026
9.2 Asia Pacific Glaucoma Pharmaceutical Market Facts & Figures by Country
9.2.1 Asia Pacific Glaucoma Pharmaceutical Sales by Region (2015-2020)
9.2.2 Asia Pacific Glaucoma Pharmaceutical Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Glaucoma Pharmaceutical Market Size YoY Growth 2015-2026
10.2 Latin America Glaucoma Pharmaceutical Market Facts & Figures by Country
10.2.1 Latin America Glaucoma Pharmaceutical Sales by Country
10.2.2 Latin America Glaucoma Pharmaceutical Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Glaucoma Pharmaceutical Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Glaucoma Pharmaceutical Market Facts & Figures by Country
11.2.1 Middle East and Africa Glaucoma Pharmaceutical Sales by Country
11.2.2 Middle East and Africa Glaucoma Pharmaceutical Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Glaucoma Pharmaceutical Products Offered
12.1.5 Pfizer Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Glaucoma Pharmaceutical Products Offered
12.2.5 Merck Recent Development
12.3 Allergan
12.3.1 Allergan Corporation Information
12.3.2 Allergan Description and Business Overview
12.3.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Allergan Glaucoma Pharmaceutical Products Offered
12.3.5 Allergan Recent Development
12.4 Santen
12.4.1 Santen Corporation Information
12.4.2 Santen Description and Business Overview
12.4.3 Santen Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Santen Glaucoma Pharmaceutical Products Offered
12.4.5 Santen Recent Development
12.5 Alcon
12.5.1 Alcon Corporation Information
12.5.2 Alcon Description and Business Overview
12.5.3 Alcon Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Alcon Glaucoma Pharmaceutical Products Offered
12.5.5 Alcon Recent Development
12.6 Teva Pharmaceuticals
12.6.1 Teva Pharmaceuticals Corporation Information
12.6.2 Teva Pharmaceuticals Description and Business Overview
12.6.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Pharmaceuticals Glaucoma Pharmaceutical Products Offered
12.6.5 Teva Pharmaceuticals Recent Development
12.7 Fera Pharmaceuticals
12.7.1 Fera Pharmaceuticals Corporation Information
12.7.2 Fera Pharmaceuticals Description and Business Overview
12.7.3 Fera Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Fera Pharmaceuticals Glaucoma Pharmaceutical Products Offered
12.7.5 Fera Pharmaceuticals Recent Development
12.8 Bausch & Lomb, Inc.
12.8.1 Bausch & Lomb, Inc. Corporation Information
12.8.2 Bausch & Lomb, Inc. Description and Business Overview
12.8.3 Bausch & Lomb, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bausch & Lomb, Inc. Glaucoma Pharmaceutical Products Offered
12.8.5 Bausch & Lomb, Inc. Recent Development
12.9 Akorn, Inc.
12.9.1 Akorn, Inc. Corporation Information
12.9.2 Akorn, Inc. Description and Business Overview
12.9.3 Akorn, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Akorn, Inc. Glaucoma Pharmaceutical Products Offered
12.9.5 Akorn, Inc. Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Glaucoma Pharmaceutical Products Offered
12.11.5 Pfizer Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Glaucoma Pharmaceutical Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glaucoma Pharmaceutical Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Glaucoma Pharmaceutical Market Segments

Table 2. Ranking of Global Top Glaucoma Pharmaceutical Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Glaucoma Pharmaceutical Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)

Table 4. Major Manufacturers of Miosis Drugs

Table 5. Major Manufacturers of Beta-blocker

Table 6. Major Manufacturers of Adrenergic Agonists

Table 7. Major Manufacturers of Carbonic Anhydrase Inhibitor

Table 8. Major Manufacturers of Prostaglandin Derivative Agent

Table 9. Major Manufacturers of Penetrates

Table 10. Global Glaucoma Pharmaceutical Market Size Growth Rate by Application 2020-2026 (K MT)

Table 11. Global Glaucoma Pharmaceutical Market Size by Region (K MT) & (US$ Million): 2020 VS 2026

Table 12. Global Glaucoma Pharmaceutical Sales by Regions 2015-2020 (K MT)

Table 13. Global Glaucoma Pharmaceutical Sales Market Share by Regions (2015-2020)

Table 14. Global Glaucoma Pharmaceutical Revenue by Regions 2015-2020 (US$ Million)

Table 15. Global Glaucoma Pharmaceutical Sales Forecast by Region (2021-2026) (K MT)

Table 16. Global Glaucoma Pharmaceutical Sales by Manufacturers (2015-2020) (K MT)

Table 17. Global Glaucoma Pharmaceutical Sales Share by Manufacturers (2015-2020)

Table 18. Global Glaucoma Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 19. Global Glaucoma Pharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glaucoma Pharmaceutical as of 2019)

Table 20. Glaucoma Pharmaceutical Revenue by Manufacturers (2015-2020) (US$ Million)

Table 21. Glaucoma Pharmaceutical Revenue Share by Manufacturers (2015-2020)

Table 22. Key Manufacturers Glaucoma Pharmaceutical Price (2015-2020) (USD/MT)

Table 23. Glaucoma Pharmaceutical Manufacturers Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Glaucoma Pharmaceutical Product Type

Table 25. Date of International Manufacturers Enter into Glaucoma Pharmaceutical Market

Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 27. Global Glaucoma Pharmaceutical Sales by Type (2015-2020) (K MT)

Table 28. Global Glaucoma Pharmaceutical Sales Share by Type (2015-2020)

Table 29. Global Glaucoma Pharmaceutical Revenue by Type (2015-2020) (US$ Million)

Table 30. Global Glaucoma Pharmaceutical Revenue Share by Type (2015-2020)

Table 31. Glaucoma Pharmaceutical Average Selling Price (ASP) by Type 2015-2020 (USD/MT)

Table 32. Global Glaucoma Pharmaceutical Sales Share by Type (2021-2026)

Table 33. Global Glaucoma Pharmaceutical Sales by Application (2015-2020) (K MT)

Table 34. Global Glaucoma Pharmaceutical Sales Share by Application (2015-2020)

Table 35. Global Glaucoma Pharmaceutical Sales Share by Application (2021-2026)

Table 36. Global Glaucoma Pharmaceutical Sales Market Share Forecast by Application (2021-2026)

Table 37. Global Glaucoma Pharmaceutical Revenue by Application (2015-2020) (US$ Million)

Table 38. Global Glaucoma Pharmaceutical Revenue Market Share Forecast by Application (2021-2026)

Table 39. United States Glaucoma Pharmaceutical Sales (K MT) of Key Companies (2015-2020)

Table 40. United States Glaucoma Pharmaceutical Sales Share by Company (2015-2020)

Table 41. United States Glaucoma Pharmaceutical Revenue (US$ Million) by Company (2015-2020)

Table 42. United States Glaucoma Pharmaceutical Sales (K MT) by Type (2015-2020)

Table 43. United States Glaucoma Pharmaceutical Sales Share by Type (2015-2020)

Table 44. United States Glaucoma Pharmaceutical Revenue (US$ Million) Market Share by Type (2015-2020)

Table 45. United States Glaucoma Pharmaceutical Price (K MT) by Type (2015-2020)

Table 46. United States Glaucoma Pharmaceutical Sales (K MT) by Type (2021-2026)

Table 47. United States Glaucoma Pharmaceutical Sales Share by Type (2021-2026)

Table 48. United States Glaucoma Pharmaceutical Revenue (US$ Million) Market Share by Type (2021-2026)

Table 49. United States Glaucoma Pharmaceutical Revenue Share by Type (2021-2026)

Table 50. United States Glaucoma Pharmaceutical Price (K MT) by Type (2021-2026)

Table 51. United States Glaucoma Pharmaceutical Sales (K MT) by Application (2015-2020)

Table 52. United States Glaucoma Pharmaceutical Sales Share by Application (2015-2020)

Table 53. United States Glaucoma Pharmaceutical Revenue (US$ Million) Market Share by Application (2015-2020)

Table 54. United States Glaucoma Pharmaceutical Sales (K MT) by Application (2021-2026)

Table 55. United States Glaucoma Pharmaceutical Sales Share by Application (2021-2026)

Table 56. United States Glaucoma Pharmaceutical Revenue (US$ Million) Market Share by Application (2021-2026)

Table 57. United States Glaucoma Pharmaceutical Revenue Share by Application (2021-2026)

Table 58. North America Glaucoma Pharmaceutical Sales by Country (2015-2020) (K MT)

Table 59. North America Glaucoma Pharmaceutical Sales Market Share by Country (2015-2020)

Table 60. North America Glaucoma Pharmaceutical Revenue by Country (2015-2020) (US$ Million)

Table 61. North America Glaucoma Pharmaceutical Revenue Market Share by Country (2015-2020)

Table 62. Europe Glaucoma Pharmaceutical Sales by Country (2015-2020) (K MT)

Table 63. Europe Glaucoma Pharmaceutical Sales Market Share by Country (2015-2020)

Table 64. Europe Glaucoma Pharmaceutical Revenue by Country (2015-2020) (US$ Million)

Table 65. Europe Glaucoma Pharmaceutical Revenue Market Share by Country (2015-2020)

Table 66. Asia Pacific Glaucoma Pharmaceutical Sales by Region (2015-2020) (K MT)

Table 67. Asia Pacific Glaucoma Pharmaceutical Sales Market Share by Region (2015-2020)

Table 68. Asia Pacific Glaucoma Pharmaceutical Revenue by Region (2015-2020) (US$ Million)

Table 69. Asia Pacific Glaucoma Pharmaceutical Revenue Market Share by Region (2015-2020)

Table 70. Latin America Glaucoma Pharmaceutical Sales by Country (2015-2020) (K MT)

Table 71. Latin America Glaucoma Pharmaceutical Sales Market Share by Country (2015-2020)

Table 72. Latin Americaa Glaucoma Pharmaceutical Revenue by Country (2015-2020) (US$ Million)

Table 73. Latin America Glaucoma Pharmaceutical Revenue Market Share by Country (2015-2020)

Table 74. Middle East and Africa Glaucoma Pharmaceutical Sales by Country (2015-2020) (K MT)

Table 75. Middle East and Africa Glaucoma Pharmaceutical Sales Market Share by Country (2015-2020)

Table 76. Middle East and Africa Glaucoma Pharmaceutical Revenue by Country (2015-2020) (US$ Million)

Table 77. Middle East and Africa Glaucoma Pharmaceutical Revenue Market Share by Country (2015-2020)

Table 78. Pfizer Corporation Information

Table 79. Pfizer Description and Business Overview

Table 80. Pfizer Glaucoma Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 81. Pfizer Glaucoma Pharmaceutical Product

Table 82. Pfizer Recent Development

Table 83. Merck Corporation Information

Table 84. Merck Description and Business Overview

Table 85. Merck Glaucoma Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 86. Merck Product

Table 87. Merck Recent Development

Table 88. Allergan Corporation Information

Table 89. Allergan Description and Business Overview

Table 90. Allergan Glaucoma Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 91. Allergan Product

Table 92. Allergan Recent Development

Table 93. Santen Corporation Information

Table 94. Santen Description and Business Overview

Table 95. Santen Glaucoma Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 96. Santen Product

Table 97. Santen Recent Development

Table 98. Alcon Corporation Information

Table 99. Alcon Description and Business Overview

Table 100. Alcon Glaucoma Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 101. Alcon Product

Table 102. Alcon Recent Development

Table 103. Teva Pharmaceuticals Corporation Information

Table 104. Teva Pharmaceuticals Description and Business Overview

Table 105. Teva Pharmaceuticals Glaucoma Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 106. Teva Pharmaceuticals Product

Table 107. Teva Pharmaceuticals Recent Development

Table 108. Fera Pharmaceuticals Corporation Information

Table 109. Fera Pharmaceuticals Description and Business Overview

Table 110. Fera Pharmaceuticals Glaucoma Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 111. Fera Pharmaceuticals Product

Table 112. Fera Pharmaceuticals Recent Development

Table 113. Bausch & Lomb, Inc. Corporation Information

Table 114. Bausch & Lomb, Inc. Description and Business Overview

Table 115. Bausch & Lomb, Inc. Glaucoma Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 116. Bausch & Lomb, Inc. Product

Table 117. Bausch & Lomb, Inc. Recent Development

Table 118. Akorn, Inc. Corporation Information

Table 119. Akorn, Inc. Description and Business Overview

Table 120. Akorn, Inc. Glaucoma Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 121. Akorn, Inc. Product

Table 122. Akorn, Inc. Recent Development

Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 124. Key Challenges

Table 125. Market Risks

Table 126. Main Points Interviewed from Key Glaucoma Pharmaceutical Players

Table 127. Glaucoma Pharmaceutical Customers List

Table 128. Glaucoma Pharmaceutical Distributors List

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Glaucoma Pharmaceutical Product Picture

Figure 2. Global Glaucoma Pharmaceutical Sales Market Share by Type in 2020 & 2026

Figure 3. Miosis Drugs Product Picture

Figure 4. Beta-blocker Product Picture

Figure 5. Adrenergic Agonists Product Picture

Figure 6. Carbonic Anhydrase Inhibitor Product Picture

Figure 7. Prostaglandin Derivative Agent Product Picture

Figure 8. Penetrates Product Picture

Figure 9. Global Glaucoma Pharmaceutical Sales Market Share by Application in 2020 & 2026

Figure 10. Hospital Pharmacy

Figure 11. Drugstore

Figure 12. Online Sales

Figure 13. Glaucoma Pharmaceutical Report Years Considered

Figure 14. Global Glaucoma Pharmaceutical Market Size 2015-2026 (US$ Million)

Figure 15. Global Glaucoma Pharmaceutical Sales 2015-2026 (K MT)

Figure 16. Global Glaucoma Pharmaceutical Market Size Market Share by Region: 2020 Versus 2026

Figure 17. Global Glaucoma Pharmaceutical Sales Market Share by Region (2015-2020)

Figure 18. Global Glaucoma Pharmaceutical Sales Market Share by Region in 2019

Figure 19. Global Glaucoma Pharmaceutical Revenue Market Share by Region (2015-2020)

Figure 20. Global Glaucoma Pharmaceutical Revenue Market Share by Region in 2019

Figure 21. Global Glaucoma Pharmaceutical Sales Share by Manufacturer in 2019

Figure 22. The Top 10 and 5 Players Market Share by Glaucoma Pharmaceutical Revenue in 2019

Figure 23. Glaucoma Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 24. Global Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)

Figure 25. Global Glaucoma Pharmaceutical Sales Market Share by Type in 2019

Figure 26. Global Glaucoma Pharmaceutical Revenue Market Share by Type (2015-2020)

Figure 27. Global Glaucoma Pharmaceutical Revenue Market Share by Type in 2019

Figure 28. Global Glaucoma Pharmaceutical Market Share by Price Range (2015-2020)

Figure 29. Global Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)

Figure 30. Global Glaucoma Pharmaceutical Sales Market Share by Application in 2019

Figure 31. Global Glaucoma Pharmaceutical Revenue Market Share by Application (2015-2020)

Figure 32. Global Glaucoma Pharmaceutical Revenue Market Share by Application in 2019

Figure 33. United States Glaucoma Pharmaceutical Sales Growth Rate 2015-2026 (K MT)

Figure 34. United States Glaucoma Pharmaceutical Revenue Growth Rate 2015-2026 (US$ Million)

Figure 35. United States Glaucoma Pharmaceutical Market Share in Global Market 2015-2026

Figure 36. United States 5 and 10 Largest Glaucoma Pharmaceutical Players Market Share by Revenue in Glaucoma Pharmaceutical in 2019

Figure 37. United States Glaucoma Pharmaceutical Revenue Share by Type (2015-2020)

Figure 38. United States Glaucoma Pharmaceutical Revenue Growth Rate by Type in 2015 & 2019

Figure 39. United States Glaucoma Pharmaceutical Revenue Share by Application (2015-2020)

Figure 40. United States Glaucoma Pharmaceutical Revenue Growth Rate by Application in 2015 & 2019

Figure 41. North America Glaucoma Pharmaceutical Sales Growth Rate 2015-2020 (K MT)

Figure 42. North America Glaucoma Pharmaceutical Revenue Growth Rate 2015-2020 (US$ Million)

Figure 43. North America Glaucoma Pharmaceutical Sales Market Share by Country in 2019

Figure 44. North America Glaucoma Pharmaceutical Revenue Market Share by Country in 2019

Figure 45. U.S. Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 46. U.S. Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 47. Canada Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 48. Canada Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 49. Europe Glaucoma Pharmaceutical Sales Growth Rate 2015-2020 (K MT)

Figure 50. Europe Glaucoma Pharmaceutical Revenue Growth Rate 2015-2020 (US$ Million)

Figure 51. Europe Glaucoma Pharmaceutical Sales Market Share by Country in 2019

Figure 52. Europe Glaucoma Pharmaceutical Revenue Market Share by Country in 2019

Figure 53. Germany Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 54. Germany Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. France Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 56. France Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. U.K. Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 58. U.K. Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Italy Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 60. Italy Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 61. Russia Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 62. Russia Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 63. Asia Pacific Glaucoma Pharmaceutical Sales Growth Rate 2015-2020 (K MT)

Figure 64. Asia Pacific Glaucoma Pharmaceutical Revenue Growth Rate 2015-2020 (US$ Million)

Figure 65. Asia Pacific Glaucoma Pharmaceutical Sales Market Share by Region in 2019

Figure 66. Asia Pacific Glaucoma Pharmaceutical Revenue Market Share by Region in 2019

Figure 67. China Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 68. China Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. Japan Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 70. Japan Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. South Korea Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 72. South Korea Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. India Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 74. India Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Australia Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 76. Australia Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Taiwan Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 78. Taiwan Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Indonesia Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 80. Indonesia Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Thailand Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 82. Thailand Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Malaysia Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 84. Malaysia Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Philippines Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 86. Philippines Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 87. Vietnam Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 88. Vietnam Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 89. Latin America Glaucoma Pharmaceutical Sales Growth Rate 2015-2020 (K MT)

Figure 90. Latin America Glaucoma Pharmaceutical Revenue Growth Rate 2015-2020 (US$ Million)

Figure 91. Latin America Glaucoma Pharmaceutical Sales Market Share by Country in 2019

Figure 92. Latin America Glaucoma Pharmaceutical Revenue Market Share by Country in 2019

Figure 93. Mexico Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 94. Mexico Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Brazil Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 96. Brazil Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 97. Argentina Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 98. Argentina Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 99. Middle East and Africa Glaucoma Pharmaceutical Sales Growth Rate 2015-2020 (K MT)

Figure 100. Middle East and Africa Glaucoma Pharmaceutical Revenue Growth Rate 2015-2020 (US$ Million)

Figure 101. Middle East and Africa Glaucoma Pharmaceutical Sales Market Share by Country in 2019

Figure 102. Middle East and Africa Glaucoma Pharmaceutical Revenue Market Share by Country in 2019

Figure 103. Turkey Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 104. Turkey Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 105. Saudi Arabia Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 106. Saudi Arabia Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 107. U.A.E Glaucoma Pharmaceutical Sales Growth Rate (2015-2020) (K MT)

Figure 108. U.A.E Glaucoma Pharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)

Figure 109. Porter's Five Forces Analysis

Figure 110. Glaucoma Pharmaceutical Value Chain

Figure 111. Channels of Distribution

Figure 112. Distributors Profiles

Figure 113. Bottom-up and Top-down Approaches for This Report

Figure 114. Data Triangulation

Figure 115. Key Executives Interviewed

Pfizer

Merck

Allergan

Santen

Alcon

Teva Pharmaceuticals

Fera Pharmaceuticals

Bausch & Lomb, Inc.

Akorn, Inc.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3315

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase